Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 30, 2025, titled "Receipt of EIR from USFDA for inspection conducted at manufacturing facility of Company s subsidiary Time-Cap Laboratories, Inc.".
Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 30, 2025, titled "Receipt of EIR from USFDA for inspection conducted at manufacturing facility of Company s subsidiary Time-Cap Laboratories, Inc.".